StockNews.com Initiates Coverage on Cutera (NASDAQ:CUTR)

Equities research analysts at StockNews.com began coverage on shares of Cutera (NASDAQ:CUTR) in a research note issued to investors on Sunday. The brokerage set a “sell” rating on the medical device company’s stock.

Cutera Price Performance

Shares of NASDAQ CUTR opened at $0.32 on Friday. Cutera has a 1 year low of $0.28 and a 1 year high of $3.00. The company has a market capitalization of $6.51 million, a price-to-earnings ratio of -0.05 and a beta of 1.32. The business has a 50-day moving average of $0.43 and a two-hundred day moving average of $0.54.

Hedge Funds Weigh In On Cutera

A hedge fund recently raised its stake in Cutera stock. Geode Capital Management LLC increased its position in shares of Cutera, Inc. (NASDAQ:CUTR) by 25.2% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 248,257 shares of the medical device company’s stock after buying an additional 50,046 shares during the quarter. Geode Capital Management LLC owned about 1.23% of Cutera worth $88,000 as of its most recent SEC filing. Institutional investors own 90.70% of the company’s stock.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.